Risk factors
Aldeyra Therapeutics (ALDX) risk factors
Item 1A of every Aldeyra Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors112 risks11 new8 dropped14 reworded
Aldeyra added 11 new risk factors focusing on FDA transparency shifts, financing dependencies on AbbVie, R&D tax changes, and cyber threats.
Filed Feb 27, 2026 - FY2024 10-K risk factors109 risks
Aldeyra Therapeutics faces significant risks from reliance on clinical trials, financing needs, manufacturing complexities, and regulatory approvals for product candidates like reproxalap.
Filed Feb 28, 2025